Grimes & Company’s Regulus Therapeutics RGLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,975
| Closed | -$17.2K | – | 394 |
|
|
2024
Q3 | $17.2K | Hold |
10,975
| – | – | ﹤0.01% | 364 |
|
|
2024
Q2 | $19.6K | Buy |
10,975
+711
| +7% | +$1.27K | ﹤0.01% | 346 |
|
|
2024
Q1 | $29.6K | Sell |
10,264
-156
| -1% | -$449 | ﹤0.01% | 341 |
|
|
2023
Q4 | $13.3K | Sell |
10,420
-127
| -1% | -$163 | ﹤0.01% | 329 |
|
|
2023
Q3 | $14.4K | Buy |
10,547
+184
| +2% | +$252 | ﹤0.01% | 307 |
|
|
2023
Q2 | $15.2K | Hold |
10,363
| – | – | ﹤0.01% | 312 |
|
|
2023
Q1 | $8.78K | Buy |
+10,363
| New | +$8.78K | ﹤0.01% | 305 |
|
|
2022
Q2 | – | Sell |
-8,820
| Closed | -$26K | – | 294 |
|
|
2022
Q1 | $26K | Buy |
8,820
+2,712
| +44% | +$8K | ﹤0.01% | 298 |
|
|
2021
Q4 | $19K | Sell |
6,108
-1,059
| -15% | -$3.29K | ﹤0.01% | 298 |
|
|
2021
Q3 | $49K | Buy |
7,167
+841
| +13% | +$5.75K | ﹤0.01% | 300 |
|
|
2021
Q2 | $51K | Buy |
6,326
+227
| +4% | +$1.83K | ﹤0.01% | 299 |
|
|
2021
Q1 | $95K | Buy |
6,099
+648
| +12% | +$10.1K | ﹤0.01% | 275 |
|
|
2020
Q4 | $74K | Buy |
5,451
+3,051
| +127% | +$41.4K | ﹤0.01% | 262 |
|
|
2020
Q3 | $12K | Buy |
2,400
+450
| +23% | +$2.25K | ﹤0.01% | 250 |
|
|
2020
Q2 | $13K | Buy |
+1,950
| New | +$13K | ﹤0.01% | 247 |
|